| Abilene Cpap Sales & Supplies, Llc | |
| 300 N Cedar St, 103, Abilene, Kansas 67410 | |
| (785) 571-5030 |
| Name | Abilene Cpap Sales & Supplies, Llc |
|---|---|
| Organization Name | Abilene Cpap Sales & Supplies Llc |
| Location | 300 N Cedar St, 103, Abilene, Kansas 67410 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (785) 571-5030 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Described recently in the Proceedings of the National Academy of Sciences, the technology is a biomedical advancement that could help unleash the potential of DNA vaccines, which despite two decades of research, have yet to make a significant impact in the treatment of major illnesses.
The U.S. Environmental Protection Agency has released a report that discusses the potential impacts of climate change on human health, human welfare, and communities in the U.S.
Researchers at the University of California, San Diego School of Medicine say overexpression of a protein called alpha-synuclein appears to disrupt vital recycling processes in neurons, starting with the terminal extensions of neurons and working its way back to the cells' center, with the potential consequence of progressive degeneration and eventual cell death.
The Global Network for Neglected Tropical Diseases' "End the Neglect" blog examines the fight against neglected tropical diseases (NTDs) in Burundi, writing, "In 2007, the Legatum Foundation, an international private investment organization that promotes sustainable development throughout the world agreed to fund the treatment of NTDs in Burundi and brought together several partners to assist Burundi's Ministry of Health."
The U.S. Food and Drug Administration today approved Prevnar 13, a pneumococcal 13-valent conjugate vaccine for infants and young children ages 6 weeks through 5 years. Prevnar 13 will be the successor to Prevnar, the pneumococcal 7-valent conjugate vaccine licensed by the FDA in 2000 to prevent invasive pneumococcal disease (IPD) and otitis media. The new vaccine extends the protection to six additional types of the disease causing bacteria.
› Verified 1 days ago
| NPI Number | 1003225210 |
| Organization Name | ABILENE CPAP SALES & SUPPLIES, LLC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 300 N Cedar St, Suite 103, Abilene, KS 67410 |
| Phone Number | 785-571-5030 |
News Archive
Described recently in the Proceedings of the National Academy of Sciences, the technology is a biomedical advancement that could help unleash the potential of DNA vaccines, which despite two decades of research, have yet to make a significant impact in the treatment of major illnesses.
The U.S. Environmental Protection Agency has released a report that discusses the potential impacts of climate change on human health, human welfare, and communities in the U.S.
Researchers at the University of California, San Diego School of Medicine say overexpression of a protein called alpha-synuclein appears to disrupt vital recycling processes in neurons, starting with the terminal extensions of neurons and working its way back to the cells' center, with the potential consequence of progressive degeneration and eventual cell death.
The Global Network for Neglected Tropical Diseases' "End the Neglect" blog examines the fight against neglected tropical diseases (NTDs) in Burundi, writing, "In 2007, the Legatum Foundation, an international private investment organization that promotes sustainable development throughout the world agreed to fund the treatment of NTDs in Burundi and brought together several partners to assist Burundi's Ministry of Health."
The U.S. Food and Drug Administration today approved Prevnar 13, a pneumococcal 13-valent conjugate vaccine for infants and young children ages 6 weeks through 5 years. Prevnar 13 will be the successor to Prevnar, the pneumococcal 7-valent conjugate vaccine licensed by the FDA in 2000 to prevent invasive pneumococcal disease (IPD) and otitis media. The new vaccine extends the protection to six additional types of the disease causing bacteria.
› Verified 1 days ago
News Archive
Described recently in the Proceedings of the National Academy of Sciences, the technology is a biomedical advancement that could help unleash the potential of DNA vaccines, which despite two decades of research, have yet to make a significant impact in the treatment of major illnesses.
The U.S. Environmental Protection Agency has released a report that discusses the potential impacts of climate change on human health, human welfare, and communities in the U.S.
Researchers at the University of California, San Diego School of Medicine say overexpression of a protein called alpha-synuclein appears to disrupt vital recycling processes in neurons, starting with the terminal extensions of neurons and working its way back to the cells' center, with the potential consequence of progressive degeneration and eventual cell death.
The Global Network for Neglected Tropical Diseases' "End the Neglect" blog examines the fight against neglected tropical diseases (NTDs) in Burundi, writing, "In 2007, the Legatum Foundation, an international private investment organization that promotes sustainable development throughout the world agreed to fund the treatment of NTDs in Burundi and brought together several partners to assist Burundi's Ministry of Health."
The U.S. Food and Drug Administration today approved Prevnar 13, a pneumococcal 13-valent conjugate vaccine for infants and young children ages 6 weeks through 5 years. Prevnar 13 will be the successor to Prevnar, the pneumococcal 7-valent conjugate vaccine licensed by the FDA in 2000 to prevent invasive pneumococcal disease (IPD) and otitis media. The new vaccine extends the protection to six additional types of the disease causing bacteria.
› Verified 1 days ago
Auburn Pharmacy Type: Pharmacy Location: 1518 N Buckeye Ave, Abilene, Kansas 67410 Phone: (785) 263-3770 | |
Abilene Cpap Sales & Supplies, Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 300 N Cedar St, Abilene, Kansas 67410 Phone: (785) 571-5030 | |
Jeffrey L Luty Od Pa Type: Medicare Supplier Location: 1000 N Brown St, Abilene, Kansas 67410 Phone: (785) 263-3651 | |
Family Eyecare Of Abilene Type: Medicare Supplier Location: 202 Nw 15th Street, Abilene, Kansas 67410 Phone: (785) 263-2020 |